Medigene Ag
(ETR) MDG1
Medigene Ag Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$16.47M
Net Income (TTM)
$45.15M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MDG1 News
MDG1: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Medigene Ag
Industry
Biotechnology
Sector
Health CareEmployees
86
CEO
Selwyn Ho, PhD
Website
www.medigene.deHeadquarters
Munich, 82152, DE
MDG1 Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-56%
Return on Capital
-66%
Return on Assets
-51%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$4.39M
Operating Income
$16.15M
EBITDA
$15.45M
Operating Cash Flow
$15.12M
Capital Expenditure
$664.00K
Free Cash Flow
$15.78M
Cash & ST Invst.
$16.67M
Total Debt
$2.95M
Medigene Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.48M
-82.3%
Gross Profit
$3.70M
-84.9%
Gross Margin
82.73%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
87
N/A
Net Income
$6.73M
-148.3%
EBITDA
$5.94M
-138.6%
Quarterly Fundamentals
Net Cash
$11.48M
-67.8%
Accounts Receivable
$499.00K
-53.6%
Inventory
$0.00
N/A
Long Term Debt
$1.61M
-43.6%
Short Term Debt
$935.00K
+6.3%
Return on Assets
-51.01%
N/A
Return on Invested Capital
-65.81%
N/A
Free Cash Flow
$7.39M
-143.3%
Operating Cash Flow
$7.09M
-141.0%